Erschienen in:
22.02.2019 | Correspondence
How useful is the LARS score in the evaluation and treatment of LARS?
verfasst von:
Y. Ribas, A. Muñoz-Duyos
Erschienen in:
Techniques in Coloproctology
|
Ausgabe 2/2019
Einloggen, um Zugang zu erhalten
Excerpt
The development of the low anterior resection syndrome (LARS) score [
1] has been extremely useful to underscore the importance of assessing functional outcomes after rectal cancer treatment. The LARS score is a validated questionnaire that, according to the authors, includes the five issues that most bother the patients: flatus incontinence, incontinence of liquid stool, frequency, clustering and urgency. The rating scale ranges from 0 to 42 points and patients are classified into three groups: “no LARS” (0–20 points), “minor LARS” (21–29 points) and “major LARS” (30–42 points). The score has been translated into several languages and it has been used in many studies, with a recent meta-analysis reporting rates of “major LARS” of 41% [
2]. In most of these studies, the LARS score was sent to the patients by post, together with a quality of life questionnaire, but did not include a clinical assessment. Moreover, the score has been used to compare functional outcomes between two surgical approaches and the effectiveness of treatments such as sacral neuromodulation. …
